|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 285.04 USD | +1.07% |
|
+9.04% | +15.62% |
| Capitalization | 8.27B 7.13B 6.63B 6.18B 11.5B 750B 12.37B 76.3B 30.09B 358B 31B 30.36B 1,306B | P/E ratio 2025 * |
42.5x | P/E ratio 2026 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise value | 7.75B 6.68B 6.22B 5.79B 10.78B 703B 11.6B 71.54B 28.21B 335B 29.06B 28.46B 1,225B | EV / Sales 2025 * |
19.9x | EV / Sales 2026 * | 13.1x |
| Free-Float |
87.7% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Krystal Biotech, Inc.
| 1 day | +1.07% | ||
| 1 week | +9.04% | ||
| Current month | +15.62% | ||
| 1 month | +20.88% | ||
| 3 months | +49.84% | ||
| 6 months | +89.84% | ||
| Current year | +15.62% |
| 1 week | 257 |  | 295.98 |
| 1 month | 231.9 | | 295.98 |
| Current year | 235.6 | | 295.98 |
| 1 year | 122.8 | | 295.98 |
| 3 years | 70.51 | | 295.98 |
| 5 years | 38.86 | | 295.98 |
| 10 years | 8.03 | | 295.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 14/04/2016 |
| Chief Executive Officer | 61 | 14/04/2016 | |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 14/04/2016 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 14/04/2016 |
Daniel Janney
BRD | Director/Board Member | 60 | 31/10/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.85% | 0.05% | 2,091 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.07% | +9.04% | +92.09% | +253.17% | 8.27B | |
| -1.20% | -7.97% | +7.55% | +0.68% | 75.21B | |
| -0.92% | +94.70% | +94.70% | +94.70% | 61.16B | |
| +2.35% | +4.24% | +38.84% | +227.42% | 58.53B | |
| +0.14% | +0.71% | -36.18% | -39.59% | 56.54B | |
| -2.46% | -12.37% | +16.98% | -43.22% | 24.12B | |
| +0.92% | -0.62% | +47.66% | +30.70% | 20.85B | |
| +0.56% | +0.22% | +198.33% | +112.59% | 19.91B | |
| +10.10% | +1.37% | +66.03% | +1,344.91% | 18.8B | |
| +6.28% | +21.95% | +22.81% | -78.06% | 16.34B | |
| Average | +1.68% | +2.89% | +54.88% | +190.33% | 35.97B | |
| Weighted average by Cap. | +0.75% | +0.76% | +39.79% | +124.69% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 389M 335M 312M 291M 541M 35.29B 582M 3.59B 1.42B 16.83B 1.46B 1.43B 61.46B | 564M 486M 452M 421M 784M 51.15B 844M 5.2B 2.05B 24.4B 2.11B 2.07B 89.1B |
| Net income | 190M 164M 153M 142M 265M 17.28B 285M 1.76B 693M 8.24B 714M 699M 30.1B | 259M 224M 208M 194M 361M 23.54B 388M 2.4B 944M 11.23B 973M 953M 41B |
| Net Debt | -516M -445M -414M -385M -717M -46.79B -772M -4.76B -1.88B -22.32B -1.93B -1.89B -81.49B | -859M -740M -689M -642M -1.19B -77.93B -1.29B -7.93B -3.13B -37.17B -3.22B -3.15B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 285.04 $ | +1.07% | 278,828 |
| 15/01/26 | 282.01 $ | -3.35% | 288,754 |
| 14/01/26 | 291.79 $ | -0.05% | 355,091 |
| 13/01/26 | 291.93 $ | +7.28% | 512,347 |
| 12/01/26 | 272.13 $ | +4.10% | 476,400 |
Delayed Quote Nasdaq, January 16, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition